What is the market for antibody therapeutics?
The market for therapeutic monoclonal antibodies is one of the most dynamic and commercially attractive sectors within the healthcare industry. Revenue for monoclonal antibodies reached over USD 19.5 billion in 2006 (Datamonitor: “Monoclonal Antibodies Report Part I”, June 2007). In 2007, total market global sales were USD 26.3 billion. Sales are forecast to increase to USD 49.1 billion in 2013, an increase in annual sales of USD 22.8B. (Datamonitor: “Monoclonal Antibodies: Update 2008”).